COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs.
Critically ill patients are easily complicated by cytokine storms, acute respiratory distress …

Background COVID 19, a lethal viral outbreak that devastated lives and the economy across
the globe witnessed non-compensable respiratory illnesses in patients. As been evaluated …

Since December 2019, coronavirus disease (COVID‐19) has rapidly swept the world. So far,
more than 30 million people have been infected and nearly one million have died. Although …

Background: In the past few years, COVID-19 became the leading cause of morbidity and
mortality worldwide. Although the World Health Organization has declared an end to COVID …

In 2019, an unprecedented disease named coronavirus disease 2019 (COVID-19) emerged
and spread across the globe. Although the rapid transmission of COVID-19 has resulted in …

At the end of 2019, a highly contagious infection began its ominous conquest of the world. It
was soon discovered that the disease was caused by a novel coronavirus designated as …

The pathogenetic mechanism of post-Covid-19 pulmonary fibrosis is currently a topic of
intense research interest, but still largely unexplored. The aim of this work was to carry out a …

Pulmonary fibrosis (PF) is a feared outcome of many pulmonary diseases which results in a
reduction in lung compliance and capacity. The development of PF is relatively rare, but it …

After the COVID-19 outbreak, increasing number of patients worldwide who have survived
COVID-19 continue to battle the symptoms of the illness, long after they have been clinically …

In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …